Treatment with Dexamethasone and Monophosphoryl Lipid A removes disease-associated transcriptional signatures in monocyte-derived dendritic cells from rheumatoid arthritis patients and confers tolerogenic features
Más información
Título de la Revista: | Frontiers in Immunology |
Volumen: | 7 |
Fecha de publicación: | 2016 |
DOI/URL: |
10.3389/fimmu.2016.00458 |